1.	Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: GLU_07, NCT00772824
2.	The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 170/11, NCT01552291
3.	Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0309006308, NCT00195013
4.	Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects Phase: Phase III Type: Supportive care Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 06.23.CLI, NCT00455247
5.	Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors Phase: Phase II Type: Supportive care Status: Active Age: 5 to 21 Sponsor: Other Protocol IDs: CDR0000492841, CPMC-AAAA6806, CPMC-ICCR-3349, NCT00365768
6.	Use of ß-hydroxy-ß-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation Phase: Phase II Type: Supportive care, Treatment Status: Approved-not yet active Age: 65 and over Sponsor: Other Protocol IDs: 00016781, NCT01607879
7.	Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EC1432-00, HARECCTR0500034, NCT00563498
8.	Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: AIRCo05.02.2009/2, NCT00922688